Bacterial biofilm formation machinery

Bacterial biofilm formation machinery refers to the integrated network of signaling pathways, enzymes, and structural proteins that enable bacteria to transition from a planktonic state to a sessile, multicellular community (Costerton et al., 1999). This process is primarily regulated by quorum sensing (QS) systems and secondary messengers like cyclic-di-GMP, which coordinate the production of extracellular polymeric substances (EPS) including polysaccharides, proteins, and extracellular DNA (Flemming & Wingender, 2010). Biofilms play a critical role in human disease by providing a protective niche that shields pathogens from the host immune system and increases antibiotic tolerance by up to 1,000-fold (Hall-Stoodley et al., 2004). Therapeutic strategies targeting this machinery include quorum quenching, enzymatic degradation of the matrix (e.g., DNase or glycosyl hydrolases), and interference with surface adhesion (Rumbaugh & Sauer, 2020). While no single biofilm receptor exists, the machinery as a whole is a major focus for treating chronic infections associated with cystic fibrosis, indwelling medical devices, and non-healing wounds (Roy et al., 2018). Drugs like Dornase alfa target the eDNA component of the machinery, while experimental agents like Dispersin B target specific matrix polysaccharides (Kaplan, 2010). The complexity of this machinery presents a challenge for drug development, as targets vary significantly between bacterial species and environmental conditions (Wu et al., 2015).

Other names

Biofilm regulatory networkQuorum sensing and biofilm machineryExtracellular polymeric substance (EPS) production systemBiofilm-associated proteins

Inhibition of quorum sensing (quorum quenching), enzymatic degradation of extracellular polymeric substances (EPS), inhibition of initial bacterial attachment, and modulation of cyclic-di-GMP signaling to induce biofilm dispersal.